Evidence map›Paper›PMID 40847020›Full record

ArticleBreast cancer (Tokyo, Japan)2025

Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02).

Hirohito Seki, Noriyuki Watanabe, Naomi Nagura, Akiko Ogiya, Ayaka Shimo, Natsue Uehiro, Wakako Tsuji, Shoichi Tomita, Takahiro Tsukioki, Hirotsugu Isaka and 5 more

Abstract readControlled Clinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hirohito SekiDepartment of Breast Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan. hirohito.seki@gmail.com.ORCID http://orcid.org/0000-0002-3211-4817
Noriyuki WatanabeDepartment of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
Naomi NaguraDepartment of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan.
Akiko OgiyaDepartment of Breast Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
Ayaka ShimoDepartment of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Natsue UehiroDepartment of Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Wakako TsujiDepartment of Breast Surgery, Shiga General Hospital, Shiga, Japan.
Shoichi TomitaDepartment of Plastic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Takahiro TsukiokiDepartment of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Hirotsugu IsakaDepartment of Breast Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan.
Tomohiro ShiraishiDepartment of Plastic Surgery, Kyorin University Hospital, Tokyo, Japan.
Yutaka NishidaCenter for Data Science Education and Research, Kyorin University, Tokyo, Japan.
Chikako YamauchiDepartment of Radiation Oncology, Shiga General Hospital, Moriyama, Shiga, Japan.
Shinsuke SasadaDepartment of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Higashihiroshima, Hiroshima, Japan.
Collaborative Study Group of Scientific Research of the Japan Oncoplastic Breast Surgery Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-mastectomy radiation therapy (PMRT) is essential for reducing recurrence in patients with high-risk breast cancer but may negatively impact breast reconstruction outcomes. The impacts of PMRT on breast satisfaction and health-related quality of life (HR-QOL) remain unclear, particularly in Japanese patients. We evaluated the impact of PMRT on breast satisfaction and HR-QOL using BREAST-Q.

methodsA multicenter, cross-sectional study was conducted at 10 institutions in Japan. Patients who underwent breast reconstruction with or without PMRT were surveyed using the Japanese version of the BREAST-Q. Endpoints included breast satisfaction and HR-QOL domains (physical, psychosocial, and sexual well-being). Multivariate analysis was performed to identify factors influencing these outcomes.

resultsOverall, 1078 patients with primary breast cancer who underwent breast reconstruction were included in this study, with a questionnaire response rate of 77.0% (830/1,078). Data from 830 patients were analyzed (PMRT group: 214, non-PMRT group: 616). The PMRT group had significantly lower breast satisfaction (50.7 vs. 57.5, P < 0.001), physical well-being (70.2 vs. 82.4, P < 0.001), and psychosocial well-being (51.2 vs. 56.4, P < 0.001). There was no significant difference in sexual well-being. PMRT was a predictor of reduced breast satisfaction, physical well-being, and psychosocial well-being.

conclusionsPMRT was associated with decreased breast satisfaction and HR-QOL in patients with reconstructed breasts. Patients should be given comprehensive information regarding the potential impacts of PMRT on breast satisfaction and HR-QOL. Shared decision-making based on realistic preoperative expectations is critical for optimal patient outcomes and satisfaction with treatment modalities.

Indexed as

Breast NeoplasmsMammaplastyPatient SatisfactionQuality of LifeAdultAgedCross-Sectional StudiesFemaleHumansJapanMastectomyMiddle AgedRadiotherapy, AdjuvantSurveys and QuestionnairesBreast cancerBREAST-QBreast reconstruction surgeryPost-mastectomy radiation therapyQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.